U.S. Diversified Financial Stock News

NYSE:VRTS
NYSE:VRTSCapital Markets

How Virtus’ New Silvant Growth Opportunities ETF (VGRO) At Virtus Investment Partners (VRTS) Has Changed Its Investment Story

In late 2025, Virtus Investment Partners expanded its actively managed ETF lineup by launching the Virtus Silvant Growth Opportunities ETF (VGRO), run by Silvant Capital Management and built on bottom-up fundamental research. This fund’s “all-weather” growth approach, combining secular and cyclical growth stocks without a strict style or factor bias, underlines Virtus’ emphasis on differentiated active management within its multi-manager ETF platform. With this new actively managed growth...
NasdaqGM:OMER
NasdaqGM:OMERPharmaceuticals

Assessing Omeros (OMER) Valuation After YARTEMLEA’s FDA Approval And Planned US Launch

Omeros (OMER) drew fresh investor attention after the U.S. Food and Drug Administration approved YARTEMLEA for hematopoietic stem cell transplant associated thrombotic microangiopathy, and the company is preparing a U.S. launch and related reimbursement infrastructure. See our latest analysis for Omeros. The FDA approval appears to be the main backdrop for recent price action, with a 30 day share price return of 50.97% and a 90 day share price return of 268.92%. Meanwhile, the 1 year total...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative

Delcath Systems recently reported publication of subgroup analyses from its phase 3 FOCUS study of the HEPZATO KIT for unresectable metastatic uveal melanoma in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across multiple patient categories. The data highlight that patients with lower tumor burden and low or normal LDH experienced meaningfully longer progression-free and overall survival, with many responses emerging only after several...
NYSE:FLUT
NYSE:FLUTHospitality

3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value

As the U.S. stock market reaches new heights, driven by geopolitical events and a surge in energy shares, investors are increasingly looking for opportunities in undervalued stocks that may offer significant potential. In this environment, identifying stocks trading below their intrinsic value can be a strategic move for those seeking to capitalize on market inefficiencies and future growth prospects.
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

3 Growth Companies With High Insider Ownership And Up To 49% Revenue Growth

As the U.S. stock market experiences a surge, with major indices like the Dow Jones and S&P 500 climbing sharply following geopolitical developments, investors are increasingly focused on identifying growth opportunities amidst this volatility. In such an environment, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business, aligning well with current market dynamics that favor robust revenue growth potential.
NYSE:NBHC
NYSE:NBHCBanks

Top Dividend Stocks To Consider In January 2026

As the U.S. stock market experiences a surge following geopolitical developments, particularly with energy shares leading the charge, investors are keenly observing how these dynamics might influence their portfolios. In such a volatile environment, dividend stocks often stand out as attractive options due to their potential for providing steady income and relative stability amidst market fluctuations.